Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Virios Therapeutics (VIRI) Tops Q2 EPS by 7c

August 11, 2022 7:19 AM EDT

Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

... More